GTR 110624067
Bids Are Invited For Registration Of Prices For The Acquisition Of Medicines For Oncology Treatment Intended To Meet Demands Arising From Legal Actions, As Well As To Meet Standardized Medicines In The High Complexity Oncology Assistance Centers (Cacon) And In The High Complexity Oncology Assistance Units (Unacon), Which Are Under The Management Of The Health Secretariats Of The Consortium Entities.
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
110624067
Tendering Authority
Subscribe to view
Tender No
90001/2026
Financer Name
Self-Funded
Work Title
Bids Are Invited For Registration Of Prices For The Acquisition Of Medicines For Oncology Treatment Intended To Meet Demands Arising From Legal Actions, As Well As To Meet Standardized Medicines In The High Complexity Oncology Assistance Centers (Cacon) And In The High Complexity Oncology Assistance Units (Unacon), Which Are Under The Management Of The Health Secretariats Of The Consortium Entities.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
30-03-2026
Closed
Work Detail
Registration Of Prices For The Acquisition Of Medicines For Oncology Treatment Intended To Meet Demands Arising From Legal Actions, As Well As To Meet Standardized Medicines In The High Complexity Oncology Assistance Centers (Cacon) And In The High Complexity Oncology Assistance Units (Unacon), Which Are Under The Management Of The Health Secretariats Of The Consortium Entities.. Leuprorelin Acetate,Leuprorelin Acetate,Leuprorelin Acetate,Leuprorelin Acetate,Calcium Folinate,Calcium Folinate,Calcium Folinate,Calcium Folinate,Zoledronic Acid,Zoledronic Acid,Abiraterone Acetate,Abiraterone Acetate,Goserelin Acetate,Goserelin Acetate,Goserelin Acetate,Goserelin Acetate,Epoetin Alpha,Epoetin Alpha,Anastrozole,Anastrozole,Atezolizumab,Atezolizumab,Azacytidine,Azacitidine,Patent Blue,Blue Patent,Bevacizumab,Bevacizumab,Bevacizumab,Bevacizumab,Bicalutamide,Bicalutamide,Blinatumomab,Blinatumomab,Bortezomib,Bortezomib,Brentuximab Vedotina,Brentuximab Vedotin,Capecitabine,Capecitabine,Cetuximab,Cetuximab,Cyclophosphamide,Cyclophosphamide,Cyclosporine,Ciclosporine,Ciclosporine,Cyclosporine,Cladribine,Cladribine,Chlorambucil,Chlorambucil,Dasatinib,Dasatinib,Doxorubicin Hydrochloride,Doxorubicin Hydrochloride,Enzalutamide,Enzalutamide,Epoetin Alfa,Epoetin Alfa,Erlotinib,Erlotinib,Everolimus,Everolimus,Exemestane,Exemestane,Filgrastim,Filgrastim,Fulvestrant,Fulvestrant,Ganciclovir Sodium,Ganciclovir Sodium,Gefitinib,Gefitinib,Gemcitabine Hydrochloride,Gemcitabine Hydrochloride,Hydroxyurea,Hydroxyurea,Imatinib Mesylate,Imatinib Mesylate,Imatinib Mesylate,Imatinib Mesylate,Lanreotide Acetate,Lanreotide Acetate,Letrozole,Letrozole,Methotrexate,Methotrexate,Nilotinib,Nilotinib,Octreotide,Octreotide,Octreotide,Octreotide,Octreotide,Octreotide,Paclitaxel,Paclitaxel,Paclitaxel,Paclitaxel
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
e6e3cf8d-b25d-45be-aa01-7c70ee468bb4.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.